ZA979906B - Synergistic gold-containing compositions. - Google Patents

Synergistic gold-containing compositions.

Info

Publication number
ZA979906B
ZA979906B ZA9709906A ZA979906A ZA979906B ZA 979906 B ZA979906 B ZA 979906B ZA 9709906 A ZA9709906 A ZA 9709906A ZA 979906 A ZA979906 A ZA 979906A ZA 979906 B ZA979906 B ZA 979906B
Authority
ZA
South Africa
Prior art keywords
gold
synergistic
disorder
containing compositions
corticosteroid
Prior art date
Application number
ZA9709906A
Other languages
English (en)
Inventor
Richard Edward Thomas
Original Assignee
Medical Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Innovations Ltd filed Critical Medical Innovations Ltd
Publication of ZA979906B publication Critical patent/ZA979906B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Contacts (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
ZA9709906A 1996-11-04 1997-11-04 Synergistic gold-containing compositions. ZA979906B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO3473A AUPO347396A0 (en) 1996-11-04 1996-11-04 Synergistic gold-containing compositions

Publications (1)

Publication Number Publication Date
ZA979906B true ZA979906B (en) 1998-05-25

Family

ID=3797784

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709906A ZA979906B (en) 1996-11-04 1997-11-04 Synergistic gold-containing compositions.

Country Status (12)

Country Link
US (2) US20020094973A1 (de)
EP (1) EP0954321B1 (de)
JP (1) JP2001508042A (de)
KR (1) KR100662888B1 (de)
CN (1) CN1130201C (de)
AT (1) ATE315398T1 (de)
AU (1) AUPO347396A0 (de)
CA (1) CA2270561A1 (de)
DE (1) DE69735091T2 (de)
ES (1) ES2256878T3 (de)
WO (1) WO1998019683A1 (de)
ZA (1) ZA979906B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836893B1 (ko) * 2006-06-23 2008-06-11 (주)두비엘 콜로이드 금의 아쥬반트로의 사용
JP4491000B2 (ja) * 2007-08-17 2010-06-30 株式会社東芝 メモリシステム
JP2011246442A (ja) * 2010-04-28 2011-12-08 Rohto Pharmaceutical Co Ltd 光老化抑制剤および皮膚菲薄化抑制剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129254T1 (de) * 1987-03-19 1995-11-15 Arthropharm Pty Ltd Antientzündungsmittel und zusammensetzungen.
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition

Also Published As

Publication number Publication date
EP0954321B1 (de) 2006-01-11
DE69735091D1 (de) 2006-04-06
AUPO347396A0 (en) 1996-12-05
ES2256878T3 (es) 2006-07-16
WO1998019683A1 (en) 1998-05-14
KR100662888B1 (ko) 2007-01-02
US20050267204A1 (en) 2005-12-01
EP0954321A4 (de) 2001-06-27
JP2001508042A (ja) 2001-06-19
EP0954321A1 (de) 1999-11-10
CN1235550A (zh) 1999-11-17
ATE315398T1 (de) 2006-02-15
CA2270561A1 (en) 1998-05-14
CN1130201C (zh) 2003-12-10
KR20000053075A (ko) 2000-08-25
US20020094973A1 (en) 2002-07-18
HK1023515A1 (en) 2000-09-15
DE69735091T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
AU4806197A (en) Method and potentiated composition for treating migraine
UA66745C2 (en) INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES
BG110703A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION
ATE268183T1 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
SG152907A1 (en) Combinations for the treatment of inflammatory disorders
UA49006C2 (uk) Похідні 6-фенілпіридил-2-аміну, фармацевтична композиція, спосіб інгібування синтази оксиду нітрогену у ссавців та спосіб лікування
BG97068A (bg) Фармацевтичен състав и метод за постигане на терапевтичен ефект
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
WO1992013553A3 (en) Method and agents for promoting wound healing
GB0001449D0 (en) Compositions
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DE69838882D1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
NZ326345A (en) Composition containing diosgenin
MX9702926A (es) L-eritrosilnucleosidos.
BG106548A (en) Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog
ZA979906B (en) Synergistic gold-containing compositions.
CA2433785A1 (en) Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose